Abbott Laboratories (ABT)
Last Price$116.830.3%
Market Cap$196.2bn
Financial profile score
5/10
LTM Revenue
$40.7 bn
+1.0% YoY
LTM Net Income
$5.6 bn
-1.3% YoY
LTM Free Cash Flow
$5.7 bn
+14.8% YoY
Net Debt
$7.8 bn
Short-term financial position
1.7x
Current Assets / Current Liabilities
ABT Income statement
Crunching data... Almost there!
Earnings growth (>10% annually)
ABT's earnings have grown by 9.0% per year over the past 5 years.
Growing Net income margin
ABT's net income margin has decreased (-1.6%)
in the last year from (15.9%) to (14.3%)
ABT Balance sheet
Crunching data... Almost there!
ABT Key balance sheet metrics
Crunching data... Almost there!
ABT Cash flow statement
Crunching data... Almost there!
ABT Key cash flow statement metrics
Crunching data... Almost there!
Growing free cash flow margin
ABT's free cash flow margin has decreased
(-5.3%)
in the last year from (17.9%) to (12.6%)
Discover more ABT fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What are Abbott Laboratories (ABT) Key Income Statement Metrics?
As of today, Abbott Laboratories last 12-month Revenue is $40.7 bn , EBITDA is $8.4 bn and Net Income is $5.6 bn , based on the financial report for June 30, 2024 (Q2 2024).
What are Abbott Laboratories (ABT) Key Balance Sheet Metrics?
As of today, Abbott Laboratories Total Assets are $73.0 bn and Total Liabilities are $33.5 bn , based on the financial report for June 30, 2024 (Q2 2024).
What are Abbott Laboratories (ABT) Key Cash Flow Statement Metrics?
As of today, Abbott Laboratories last 12-month Cash Flow from Operating Activities is $2 bn, Cash Flow from Investing Activities is $-0.5 bn and Cash Flow from Financing Activities is $-0.8 bn, based on the financial report for June 30, 2024 (Q2 2024).
What is Abbott Laboratories (ABT) Free Cash Flow?
As of today, Abbott Laboratories last 12-month Free Cash Flow is $5.7 bn , based on the financial report for June 30, 2024 (Q2 2024).